Interferon alfa-2b biosimilar (SRC VB Vector/Vector-Medica)

干扰素α-2b生物类似药（SRC VB Vector/Vector-Medica）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b biosimilar (SRC VB Vector/Vector-Medica)
Drug Alias Name干扰素α-2b生物仿制药（SRC VB Vector/Vector-Medica）Reaferon-ECReaferon-EU
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNeoplasmsHepatitis CHepatitis B
Global Approved IndicationsNeoplasmsHepatitis CHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date1993/12/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVector MedicaState Research Center Of Virology And Biotechnology Vector
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsNeoplasmsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A